PF-Atlas › Clinical Trials › NCT03104322

Patient-reported Monitoring of Symptoms and Spirometry Via the patientMpower Platform in Idiopathic Pulmonary Fibrosis

patientMpower platform · Not specified

Registry ID
NCT03104322
Phase
Not specified
Status
Completed
Drug / intervention
patientMpower platform
Sponsor
patientMpower Ltd.
Start
2017-06-15
Enrollment
7
Locations
1

About this trial

Pilot-scale, open-label, fixed-order, two-period crossover study in idiopathic pulmonary fibrosis (IPF) over 16 weeks. Patients will use an electronic health journal (patientMpower platform) to record treatment compliance, forced vital capacity (FVC; daily), impact of IPF on daily life (weekly) and other symptoms. Objectives are to characterise acceptability of patientMpower platform from patient \& healthcare professional perspective, impact of active engagement and self-monitoring using patientMpower platform on Patient Reported Outcome Measures (PROMs) in IPF, impact of patientMpower platform on medication compliance and correlation between patient-reported PROMs \& FVC and clinical outcomes.

View NCT03104322 on ClinicalTrials.gov →

Explore related

All patientMpower platform trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT03104322 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.